New Details on the Revision of USP Chapter 1

Recommendation
13/14 May 2025
GM Requirements for Planning, Qualification and Operation
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
23.04.2025Data Integrity Violations at an OTC Manufacturer
23.04.2025Warning Letter to Indian API Manufacturer due to Restricted Access
16.04.2025Warning Letter to Chinese API Manufacturer
09.04.2025GMP Violations by Chinese OTC Manufacturer
26.03.2025Pharmaceutical Construction Sites: Dealing with Documents in Piping Construction
19.03.2025New VDI Guideline 6022 Blatt 8.1 - Cleaning of Ventilation and Air-Conditioning Systems